Vyant Bio Overview

  • Founded
  • 1999

Founded
  • Status
  • Public

  • Employees
  • 72

Employees
  • Stock Symbol
  • VYNT

Stock Symbol
  • Investments
  • 5

  • Share Price
  • $0.55

  • (As of Wednesday Closing)

Vyant Bio General Information

Description

Vyant Bio Inc is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. Its Central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. The company's platform is designed to elucidate disease pathophysiology; formulate key therapeutic hypotheses; identify and validate drug targets, cellular assays, and biomarkers to guide candidate molecule selection; and guide clinical trial patient selection and trial design. The company derives prime revenue from the U.S.

Contact Information

Formerly Known As
Cancer Genetics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 2 Executive Campus
  • 2370 State Route 70 West, Suite 310
  • Cherry Hill, NJ 08002
  • United States
+1 (201) 000-0000

Vyant Bio Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vyant Bio Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.55 $0.54 $0.50 - $3.24 $16.1M 29.3M 26.5K -$1.69

Vyant Bio Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 12,580 16,933
Revenue 1,974 1,148 867 605
EBITDA (14,571) (17,149) (7,005) (8,047)
Net Income (44,275) (40,859) (8,650) (8,956)
Total Assets 26,811 37,636 4,049 4,193
Total Debt 2,191 1,197 7,952 1,384
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vyant Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vyant Bio‘s full profile, request access.

Request a free trial

Vyant Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Vyant Bio‘s full profile, request access.

Request a free trial

Vyant Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Vyant Bio Inc is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neuro
Pharmaceuticals
Cherry Hill, NJ
72 As of 2021
000.00
000000000 000.00

000000

olore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
000000000000000
Ardsley, NY
000 As of 0000
00000
0.00 0000-00-00
000000&0

000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000 000000000
San Diego, CA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vyant Bio Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Acorda Therapeutics Formerly VC-backed Ardsley, NY 000 00000 000000&0
0000000 00000000 Formerly Angel backed San Diego, CA 00 00000 000000000 00000
000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
00000 000000000000 Venture Capital-Backed Didcot, United Kingdom 0 00000 00000000000 00000
000000000 Corporation Epalinges, Switzerland 00 0000000000
You’re viewing 5 of 19 competitors. Get the full list »

Vyant Bio Patents

Vyant Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160130665-A1 Prognostic methods and systems for chronic lymphocytic leukemia Inactive 11-Nov-2014 0000000000
CA-2901543-A1 Methods and tools for the diagnosis and prognosis of urogenital cancers Inactive 15-Feb-2013 0000000000
EP-2956551-A1 Methods and tools for the diagnosis and prognosis of urogenital cancers Inactive 15-Feb-2013 0000000000
US-20140235458-A1 Methods and tools for the diagnosis and prognosis of urogenital cancers Inactive 15-Feb-2013 0000000000
US-8865882-B2 Methods for detecting human papilloma virus-associated cancers Active 08-Sep-2010 C12Q1/708 00
To view Vyant Bio’s complete patent history, request access »

Vyant Bio Executive Team (18)

Name Title Board Seat Contact Info
John Roberts Chief Executive Officer, President & Board Member
Andrew LaFrence Chief Financial Officer, Finance
Igor Gitelman Chief Accounting Officer
Robert Fremeau Jr. Chief Scientific Officer
Yung-Ping Yeh Board Member & Executive
You’re viewing 5 of 18 executive team members. Get the full list »

Vyant Bio Board Members (11)

Name Representing Role Since
Geoffrey Harris Ph.D Self Board Member 000 0000
Howard McLeod Ph.D Self Board Member 000 0000
Joanna Horobin Vyant Bio Board Member 000 0000
John Roberts Vyant Bio Chief Executive Officer, President & Board Member 000 0000
Yung-Ping Yeh Vyant Bio Board Member & Executive 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Vyant Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vyant Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vyant Bio‘s full profile, request access.

Request a free trial

Vyant Bio Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 30-Mar-2021 0000000000 000.00 Biotechnology 0000 0000
000000000 15-Aug-2017 0000000000 00.00 Other Pharmaceuticals and Biotechnology 00000 000
00000000 0000 09-Oct-2015 0000000000 000.00 Diagnostic Equipment 000000 00
0000000 16-Jul-2014 0000000000 00.000 Practice Management (Healthcare) 00000 000
Cancer Genetics India 15-May-2014 Merger/Acquisition 00.00 Laboratory Services (Healthcare) 00000 000
To view Vyant Bio’s complete acquisitions history, request access »

Vyant Bio Subsidiaries (2)

Company Name Industry Location Founded
StemoniX Biotechnology Maple Grove, MN 2014
000000000 Other Pharmaceuticals and Biotechnology Bundoora, Australia 0000
To view Vyant Bio’s complete subsidiaries history, request access »

Vyant Bio Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000 00 15-May-2014 000000000000000000 00.00 Completed
  • 00000 000
To view Vyant Bio’s complete exits history, request access »